Back to Search Start Over

Long-term follow up of Hodgkin lymphoma

Authors :
Juan Cristobal Sanchez
Beatriz Nuñez
David Pérez-Callejo
María Auxiliadora Brenes
Fernando Franco
Virginia Calvo
Lorea Zurutuza
Miriam Mendez
Ana Royuela
Maria Torrente
Mariano Provencio
UAM. Departamento de Medicina
Source :
Biblos-e Archivo. Repositorio Institucional de la UAM, instname, Oncotarget
Publication Year :
2018
Publisher :
Impact Journals, 2018.

Abstract

// David Perez-Callejo 1, * , Lorea Zurutuza 1, * , Ana Royuela 2 , Maria Torrente 1 , Beatriz Nunez 1 , Virginia Calvo 1 , Miriam Mendez 1 , Fernando Franco 1 , Maria Auxiliadora Brenes 1 , Juan Cristobal Sanchez 1 and Mariano Provencio 1 1 Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain 2 Statistics Department, Hospital Universitario Puerta de Hierro–Majadahonda, Madrid, Spain * These authors contributed equally to this work Correspondence to: Mariano Provencio, email: mariano.provencio@salud.madrid.org Keywords: Hodgkin lymphoma; survival; standardized mortality ratio Received: September 27, 2017 Accepted: January 13, 2018 Published: February 03, 2018 ABSTRACT Background: Hodgkin lymphoma (HL) is the paradigm of curable disease. This study analyzed the overall survival (OS) of patients with HL and compared their survival between decades and with the expected survival of a general population. Results: The median follow-up was 22 years. The median OS was 33 years. The incidence mortality rate for all causes is 2 per every 100 patients per year. The OS of our cohort at 10 years from diagnosis was 76% (95% CI: 72–79) and 52% at 30 years (95% CI: 48–57). Overall SMR (1980–2013) was 2,943 (95% CI: 2,518–3,439). Excluding the primary tumor as the cause of death, the SMR obtained is 2,266 (95% CI: 1,895–2,710). The SMR for those patients diagnosed before the year 2000 was 2,097 (95% CI: 1,732–2,539); and for those diagnosed after 2000 was 5,218 (95% CI: 8,655). The group of patients diagnosed after 2000 had statistically significant more advanced stages, were older and less responsive to treatment. Conclusions: Despite the advances achieved, the risk of death remains higher than in the general population, mainly for those patients diagnosed after year 2000, even after almost 40 years of follow-up. This data might suggest a shift to more aggressive forms of disease in recent years. Patients and methods: A total of 595 patients diagnosed with HL were included between January 1966 and February 2014. The standardized mortality ratio (SMR) was analyzed using the annual rate of mortality in the general Spanish population, adjusted for age, sex and time period.

Details

Database :
OpenAIRE
Journal :
Biblos-e Archivo. Repositorio Institucional de la UAM, instname, Oncotarget
Accession number :
edsair.doi.dedup.....5e0a51b92356c67cd38dcd9065e46de8